Quantification of cisplatin, carboplatin and oxaliplatin in spiked human plasma samples by ICP-SFMS and hydrophilic interaction liquid chromatography (HILIC) combined with ICP-MS detection†
Abstract
Therapeutic
* Corresponding authors
a
University of Natural Resources and Applied Life Sciences – BOKU Vienna, Muthgasse 18, Vienna
E-mail:
stephan.hann@boku.ac.at
b Johannes-Kepler-University Linz, Institute of Analytical Chemistry, Altenberger Straße 69, Linz, Austria
c Department of Medicine I, Clinical Division of Oncology, Medical University of Vienna, Waehringer Guertel 18-20, Vienna
Therapeutic
T. Falta, G. Koellensperger, A. Standler, W. Buchberger, R. M. Mader and S. Hann, J. Anal. At. Spectrom., 2009, 24, 1336 DOI: 10.1039/B907011G
To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.
If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.
If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.
Read more about how to correctly acknowledge RSC content.
Fetching data from CrossRef.
This may take some time to load.
Loading related content